Literature DB >> 22023466

Iron chelation therapy with deferasirox results in recovery of hematopoiesis in a child with aplastic anemia.

Jae Wook Lee, Pil-Sang Jang, Nack-Gyun Chung, Bin Cho, Dae-Chul Jeong, Hack-Ki Kim.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22023466     DOI: 10.3109/08880018.2011.615050

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


× No keyword cloud information.
  5 in total

1.  Iron chelation of hetrombopag in aplastic anemia: a post hoc analysis of a phase II study.

Authors:  Wenrui Yang; Xin Zhao; Guangsheng He; Hong Chang; Bing Han; Sujun Gao; Shunqing Wang; Tong Chen; Fei Li; Yi Wang; Xiaoyan Ge; Rong Fu; Zheng Ge; Yingmei Li; Hong Liu; Xinjian Liu; Miao Miao; Liansheng Zhang; Fengkui Zhang
Journal:  Ann Hematol       Date:  2022-10-11       Impact factor: 4.030

2.  Hematologic responses in patients with aplastic anemia treated with deferasirox: a post hoc analysis from the EPIC study.

Authors:  Jong Wook Lee; Sung-Soo Yoon; Zhi Xiang Shen; Arnold Ganser; Hui-Chi Hsu; Ali El-Ali; Dany Habr; Nicolas Martin; John B Porter
Journal:  Haematologica       Date:  2013-04-12       Impact factor: 9.941

3.  Safety and efficacy of deferasirox in the management of transfusion-dependent patients with myelodysplastic syndrome and aplastic anaemia: a perspective review.

Authors:  Rebecca L C Adams; Robert J Bird
Journal:  Ther Adv Hematol       Date:  2013-04

Review 4.  Physiology and pathophysiology of iron in hemoglobin-associated diseases.

Authors:  Thomas D Coates
Journal:  Free Radic Biol Med       Date:  2014-04-12       Impact factor: 7.376

Review 5.  Recent advances in treatment of aplastic anemia.

Authors:  Seung Hwan Shin; Sung Eun Lee; Jong Wook Lee
Journal:  Korean J Intern Med       Date:  2014-10-31       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.